It typically improves as your body adjusts
Los pacientes que toman semaglutida tenan un mayor riesgo de desarrollar problemas estomacales graves como obstruccin intestinal y gastroparesia (cuando el estmago ralentiza o detiene por completo el movimiento de los alimentos hacia el intestino delgado), segn un estudio de JAMA Ophthalmology
however, human data to date do not show an elevated cancer risk
Estos tratamientos mejoran la eficacia respecto a frmacos previos como Ozempic, al combinar mecanismos y aumentar la respuesta metablica
Visit wellstar.org/cancercare to learn more about fighting cancer with Wellstar
Based on the overall evidence around nutrition and obesity including potential impacts on metabolism, the microbiome, thermogenesis, and epigenetics, the authors of this Advisory recommend eating more minimally processed, nutrient-dense foods and fewer starch and sugar rich ultraprocessed foods for optimizing weight reduction while using GLP-1s (Table 6)